Mutations in the FLNA gene cause a remarkably broad set of disorders, collectively called filaminopathies, that can affect the brain, skeleton, heart, lungs, gut, and blood. The gene sits on the X chromosome, which means males and females experience these conditions very differently, and the specific type of mutation determines which organ systems are hit hardest. Because filamin A protein interacts with over 90 other molecules in the body, even small changes in the gene can ripple outward in unpredictable ways.
What Filamin A Actually Does
Filamin A is a large scaffolding protein whose main job is cross-linking actin filaments, the structural fibers that give cells their shape and allow them to move. It connects these fibers at roughly right angles, creating a flexible mesh that lets cells maintain their form under mechanical stress while still being able to migrate, stretch, and divide.1PubMed Central. Molecular Tuning of Filamin A Activities in the Context of Adhesion and Migration The protein was first identified in 1975 as the first non-muscle actin cross-linker, and decades of work since then have revealed that it does far more than structural housekeeping. Filamin A binds to receptors, ion channels, signaling molecules, and even transcription factors, making it a hub that coordinates how cells respond to their environment.2PubMed Central. The filamins: organizers of cell structure and function
This dual role as both structural scaffold and signaling platform is why FLNA mutations cause such varied problems. In developing brain tissue, filamin A guides neurons as they migrate to their final positions. In heart valves, it helps maintain the connective tissue that keeps leaflets flexible but strong. In the gut wall, it supports the smooth muscle cells that propel food along. Disrupt any of those functions and you get a different clinical picture, sometimes within the same family carrying the same mutation.
Loss of Function Versus Gain of Function
Not all FLNA mutations do the same thing to the protein. The distinction between loss-of-function and gain-of-function mutations is one of the most important concepts for understanding why different families with FLNA problems can look so clinically different from one another.
Loss-of-function mutations reduce or eliminate the protein’s activity. These tend to cause periventricular nodular heterotopia, a brain malformation where neurons fail to migrate to the cortex, and are also associated with cardiovascular defects like aortic aneurysms and valve problems.3Journal of Medical Genetics. Familial periventricular nodular heterotopia, epilepsy and Melnick–Needles Syndrome caused by a single FLNA mutation with combined gain-of-function and loss-of-function effects Gain-of-function mutations, by contrast, produce a protein that works in an abnormal or excessive way. These are linked to a group of skeletal dysplasias called the otopalatodigital spectrum disorders, which affect bone and cartilage development. Gain-of-function variants are typically missense mutations or small deletions that preserve the reading frame.4PubMed Central. Otopalatodigital Syndrome Type I: Novel Characteristics and Prenatal Manifestations in two Siblings
In rare cases, a single mutation can produce both effects simultaneously. One family reported in the literature carried a FLNA variant that caused periventricular nodular heterotopia with epilepsy in some members and Melnick-Needles syndrome, a skeletal condition, in others.3Journal of Medical Genetics. Familial periventricular nodular heterotopia, epilepsy and Melnick–Needles Syndrome caused by a single FLNA mutation with combined gain-of-function and loss-of-function effects Findings like these make genetic counseling particularly challenging, because the same mutation can present very differently even among blood relatives.
Why Sex Makes Such a Difference
FLNA sits on the X chromosome, and this has profound consequences for how severe the disease is in males versus females. Females carry two X chromosomes, so if one copy of FLNA is mutated, the other copy can partially compensate through a process called X-inactivation, where each cell randomly silences one X chromosome. This means that in any given tissue, roughly half the cells may produce normal filamin A while the other half do not.
Males have only one X chromosome. A loss-of-function mutation leaves them with no working copy of the protein at all. For many FLNA mutations, this is incompatible with survival. Males with periventricular nodular heterotopia caused by FLNA loss-of-function variants typically die before or shortly after birth; only those with mutations near the far end of the gene or those who are mosaic (carrying the mutation in only some cells) tend to survive.5PubMed Central. Characterization of a Splice Variant in FLNA Associated With Periventricular Nodular Heterotopia Males who do survive tend to have more severe connective tissue, cardiovascular, and gastrointestinal problems than their female relatives with the same mutation.6BMC Medical Genetics. FLNA mutations in surviving males presenting with connective tissue findings: two new case reports and review of the literature
This sex-linked pattern means that when clinicians see a family in which several females have seizures or heart valve problems while male pregnancies end in miscarriage, FLNA should be high on the list of genes to test.
Periventricular Nodular Heterotopia and Epilepsy
The neurological hallmark of FLNA loss-of-function mutations is periventricular nodular heterotopia, often abbreviated PNH. During fetal brain development, neurons are born near the brain’s inner ventricles and then migrate outward to the cortex. When filamin A is missing or defective, some neurons get stuck along the ventricle lining, forming clumps (nodules) of misplaced gray matter that can be seen on MRI. These nodules are the defining feature of the condition and are strongly associated with epilepsy.5PubMed Central. Characterization of a Splice Variant in FLNA Associated With Periventricular Nodular Heterotopia
Seizures are the most common symptom, but they do not appear in every carrier. In a study of 47 patients with FLNA-associated PNH, ten mutation carriers remained seizure-free at a median age of about 20 years.7PubMed Central. 47 patients with FLNA associated periventricular nodular heterotopia For those who do develop epilepsy, seizure onset can range from childhood to early adulthood, and seizures are sometimes the very first clue that prompts imaging and a diagnosis. Intelligence is usually in the normal range, though some individuals may have learning difficulties or mild cognitive effects. PNH caused by FLNA variants has also been linked in broader reviews to Ehlers-Danlos syndrome features and other cognitive impairments, underscoring that brain involvement is not limited to seizures alone.8PubMed Central. The Emerging Role of Filamin A and FLNA Gene in Central Nervous System Functions: Insights into Neurodevelopment and Disease
Skeletal Dysplasias in the Otopalatodigital Spectrum
The gain-of-function side of the FLNA mutation spectrum produces a cluster of bone and cartilage disorders collectively called otopalatodigital spectrum disorders, or OPDSD. The name comes from the body parts most often affected: the ears (oto-), palate (palato-), and fingers and toes (digital). These conditions range in severity from relatively mild to lethal.
At the milder end is otopalatodigital syndrome type I, which causes hearing loss, a cleft or high-arched palate, and broad or short fingers and toes. Type II is more severe and often fatal in males, with widespread skeletal abnormalities including bowed long bones, underossified skulls, and omphalocele. Frontometaphyseal dysplasia sits in the middle of the spectrum and features thickened skull bones (hyperostosis) combined with abnormal shaping of the long bones, plus extra-skeletal problems in the airways, heart, and urinary tract.9PubMed. Frontometaphyseal dysplasia: mutations in FLNA and phenotypic diversity
Melnick-Needles syndrome represents one of the more severe OPDSD phenotypes. It is an extremely rare X-linked dominant condition characterized by short stature, distinctive facial features, and widespread skeletal abnormalities including kyphoscoliosis, thin wavy ribs, and hip malformations.10PubMed Central. A family of Melnick-Needles syndrome: a case report Like OPD type II, Melnick-Needles syndrome is typically lethal in males, so nearly all diagnosed patients are female.11PubMed. FLNA Variants Related to Melnick-Needles Syndrome: Two Mexican Case Reports and a Comprehensive Variant Review Systemic complications beyond the skeleton can include respiratory and cardiac involvement.
Another rare member of the FLNA skeletal family is terminal osseous dysplasia, which affects only females and is lethal in males. It causes skeletal abnormalities mainly in the limbs, skin pigmentation changes, and recurring digital fibromas that appear in infancy, caused by a single recurrent FLNA mutation.12PubMed Central. Terminal osseous dysplasia is caused by a single recurrent mutation in the FLNA gene
Heart Valve Disease and Aortic Aneurysms
Cardiovascular problems are among the most clinically significant complications of FLNA mutations, partly because they can go undetected until a medical emergency occurs. Filamin A was identified as the first gene responsible for non-syndromic mitral valve dystrophy, a condition in which the mitral valve leaflets become thickened and floppy (prolapsing) without being part of a broader genetic syndrome like Marfan syndrome.13PubMed Central. New insights into mitral valve dystrophy: a Filamin-A genotype–phenotype and outcome study Multiple distinct FLNA missense mutations and deletions have been identified in unrelated families with X-linked mitral valve dystrophy.14PubMed. Mutations in the gene encoding filamin A as a cause for familial cardiac valvular dystrophy The valve tissue in affected individuals shows the hallmarks of myxomatous degeneration: thickened leaflets, excessive cell growth, and accumulation of proteoglycans, the gel-like molecules in connective tissue.15European Heart Journal. Functional, structural and molecular characterization of a new mitral valve prolapse animal model: the FLNA-P637Q KI rat
Aortic aneurysms are the other major cardiovascular threat. In the largest published series of patients with loss-of-function FLNA mutations, thoracic aortic aneurysms or dilation appeared in about 18% of patients. More than half of those with aneurysms also had other structural heart defects, most commonly patent ductus arteriosus and valve abnormalities. Roughly a third of the aneurysms involved the sinus of Valsalva, and about 29% required surgery. Perhaps most alarming, aortic complications were the only recorded cause of non-accidental premature death in adults in the series. Two patients died of spontaneous aortic rupture at aortic dimensions smaller than the usual thresholds for preventive surgery in other aortic conditions, suggesting that standard surgical guidelines may not apply to FLNA patients.16PubMed Central. Thoracic aortic aneurysm in patients with loss of function Filamin A mutations: Clinical characterization, genetics, and recommendations
Because aortic aneurysms can develop silently, screening family members is important. A case report described a 47-year-old woman with a previously repaired ascending aortic aneurysm who developed a new aneurysm; genetic testing revealed an FLNA mutation, and her mother subsequently tested positive and was found to have her own aneurysm on screening.17PubMed Central. Heritable FLNA Gene Mutation in a Patient With Thoracic Aortic Aneurysm In another family, a young woman with acute aortic dissection and her child with an aortic aneurysm were both found to carry FLNA mutations alongside a second aortic disease gene, illustrating that multiple mutations can co-occur and push onset to an even younger age.18Internal Medicine. Double Mutations in the FLNA and MYH11 Genes Causing Familial Thoracic Aortic Aneurysm and Dissection: A Report of Two Cases
Lung Disease
Respiratory complications are less widely recognized than the neurological or cardiac features but can be life-threatening, especially in males. A male infant with a novel FLNA deletion developed progressive emphysematous lung disease with interstitial involvement during the first months of life. After surgical removal of an affected lung lobe, he progressed to chronic respiratory failure requiring a tracheostomy and long-term mechanical ventilation. In his case, the lung problems were actually the first sign of the underlying FLNA disorder, preceding the discovery of periventricular nodular heterotopia on brain imaging.19PubMed Central. Congenital emphysematous lung disease associated with a novel Filamin A mutation. Case report and literature review
Another male patient was reported with severe lung disease from three months of age, including recurrent respiratory infections, bilateral lung collapse, lung cysts, floppy airways (tracheobronchomalacia), pulmonary hypertension, and long-term oxygen dependence. Pathology of the removed lung tissue showed widespread emphysema and a marked reduction in the cartilage that normally holds the small airways open.20European Journal of Medical Genetics. Lung disease associated with periventricular nodular heterotopia and an FLNA mutation These reports suggest that filamin A plays a structural role in airway and lung tissue development, and that respiratory symptoms in a young child with a known or suspected FLNA mutation should not be attributed to ordinary infections without further investigation.
Gastrointestinal Problems
Gut motility disorders, particularly chronic intestinal pseudo-obstruction (CIPO), are a well-documented complication of FLNA mutations. In pseudo-obstruction, the bowel behaves as though it is blocked even when no physical obstruction exists, leading to severe bloating, pain, vomiting, and inability to tolerate oral feeding. The problem in FLNA-related cases appears to be rooted in the smooth muscle of the intestinal wall rather than in the nerves that control it. Pathology studies of affected males have found abnormal layering of the intestinal muscle, including areas where muscle cells were disorganized and multinucleated, with severely reduced filamin A staining.21PubMed. Diffuse abnormal layering of small intestinal smooth muscle is present in patients with FLNA mutations and x-linked intestinal pseudo-obstruction These histological features appear to be specific to FLNA-related pseudo-obstruction and point to a fundamentally myopathic (muscle-based) cause of the dysmotility.22Human Molecular Genetics. The long Filamin-A isoform is required for intestinal development and motility: implications for chronic intestinal pseudo-obstruction
While intestinal pseudo-obstruction has traditionally been described in boys and men with FLNA mutations, a recent case expanded the picture by documenting a late-onset form of CIPO in an adult patient caused by a missense mutation in the long isoform of FLNA. This mutation did not eliminate the protein entirely but was predicted to alter its folding in a way that impairs actin cross-linking in visceral smooth muscle.23PubMed Central. A unique case of late-onset CIPO caused by a missense mutation in the long isoform of FLNA The finding is clinically relevant because it means that FLNA-related gut problems are not exclusively a pediatric diagnosis.
Thrombocytopenia and Platelet Dysfunction
A less well-known consequence of FLNA mutations is abnormal platelet production and function. Some patients develop macrothrombocytopenia, meaning they have too few platelets and the ones they do produce are abnormally large. This can sometimes be the only obvious clinical feature, presenting as an isolated bleeding tendency that initially gets attributed to more common causes before genetic testing reveals the underlying FLNA defect.24Blood. Thrombocytopenia resulting from mutations in filamin A can be expressed as an isolated syndrome
The platelet problems are not uniform among FLNA mutation carriers. A study of patients with different FLNA variants found that some had reduced platelet aggregation, impaired signaling through key collagen receptors, and decreased thrombus formation, while one patient with a different mutation type had entirely normal platelet function despite carrying a truncating FLNA variant and having periventricular nodular heterotopia.25PubMed. Heterogeneity of platelet functional alterations in patients with filamin A mutations This variability means that platelet testing should be considered in any FLNA mutation carrier, but normal results on one test do not rule out other FLNA-related complications.
When Multiple Organ Systems Overlap
One of the most challenging aspects of FLNA-related disease is that any individual patient may have involvement in several organ systems at once, and the combination is not always predictable from the mutation alone. A case report described a patient with an FLNA missense mutation who presented with both aortic and mitral valve disease severe enough to require double mechanical valve replacement, alongside connective tissue, pulmonary, and skeletal abnormalities.26JACC: Case Reports. FLNA Mutations in Multisystem Disease: A Diagnostic Key for Unexplained Valvular and Connective Tissue Disorder In practice, this means that once an FLNA mutation is identified in a patient presenting with one problem (say, seizures or a heart murmur), clinicians should look systematically at the other organ systems known to be affected. The cardiovascular findings, in particular, deserve ongoing surveillance given the risk of aortic complications at relatively modest vessel sizes.
For surviving males, the multisystem picture tends to be broader and more severe. Connective tissue laxity, joint hypermobility, and skin hyperextensibility can mimic Ehlers-Danlos syndrome, and some males have been diagnosed with connective tissue disorders for years before genetic testing identifies the FLNA mutation as the underlying cause.6BMC Medical Genetics. FLNA mutations in surviving males presenting with connective tissue findings: two new case reports and review of the literature
Prenatal Detection and Family Planning
Because many FLNA mutations are inherited rather than arising spontaneously, prenatal diagnosis is relevant for families with a known variant. Ultrasound can sometimes provide the first clue: an enlarged cisterna magna identified during a second-trimester scan has been reported in cases later confirmed as FLNA-related periventricular nodular heterotopia by genetic testing. Early prenatal diagnosis allows parents time to make informed decisions and opens the door to preimplantation genetic testing in future pregnancies for female carriers.27Journal of Medical Ultrasound. Prenatal Diagnosis of FLNA-related Cerebral Periventricular Nodular Heterotopia Presented with Enlarged Cisterna Magna Identified in the Second Trimester: Two Cases Report
Preimplantation genetic testing for monogenic disorders, or PGT-M, is an option for women with FLNA mutations who wish to have children without passing on the variant. The procedure involves creating embryos through IVF, testing each for the specific mutation, and transferring only unaffected embryos. For women who themselves have epilepsy from FLNA-related PNH, this approach carries additional considerations around managing seizure medications during the IVF process. As with all PGT-M applications, the procedure raises ethical discussions around cost, accessibility, and the decision of which conditions warrant embryo selection, but for families who have watched male pregnancies end in loss or seen severe multisystem disease in affected relatives, it can be a meaningful option to discuss with a genetics team.